TABLE I. Demographical and clinical characteristics of cutaneous leishmaniasis (CL) patients treated with meglumine antimoniate (MA) intralesional infiltration in a Brazilian referral centre.
| Characteristics | 53 patients, 62 lesions |
| Age (median, IQR), years | 42 (31-58) |
| Sex (male: female) | 29:17 |
| Lesion location, No. (%) | |
| Lower limbs | 25/62 (40) |
| Arms/hand | 24/62 (39) |
| Trunk | 8/62 (13) |
| Head/neck | 5/62 (8) |
| Number of lesions per patient (mean, SD) | 1.17 ± 0.47 |
| Feature of the main lesion: ulcerated, n (%) | 49/62 (92) |
| Site of the main lesion: lower limbs, n (%) | 23/62 (43) |
| Total lesions area (Median, IQR), mm2 | 462 (212-703) |
| Diameter of the main lesion (Median, IQR), mm | 25 (16.5-31) |
| Montenegro skin test positivity, n/N (%) | 19/22 (86) |
| Imprint smear positive, n/N (%) | 33/44 (75) |
| Leishmania culture positive, n/N (%) | 37/48 (77) |
| Positive Leishmania PCR, n/N (%) | 7/7 (100) |
| Illness duration before treatment (median, IQR), weeks | 10 (8-16) |
| Hypertension, n (%) | 13/53 (24) |
| Diabetes, n (%) | 1/53 (2) |
IQR: 25-75% interquartile range; SD: standard deviation; N: number of patients tested; PCR: polymerase chain reaction.